Sarilumab Suppliers & Bulk Manufacturers
Available Forms: injection (prefilled syringe)
Available Strengths: 150 mg/1.14 mL, 200 mg/1.14 mL
Reference Brands: Kevzara (USA/EU)
Category:
Immune Disorder
Sarilumab is a fully human monoclonal antibody that targets the interleukin‑6 (IL‑6) receptor (both membrane‑bound and soluble forms). By blocking IL‑6 from binding to its receptor, sarilumab inhibits the IL-6 mediated inflammatory signaling pathway. This reduces inflammation, immune‑mediated damage, and other symptoms associated with autoimmune inflammatory diseases such as rheumatoid arthritis and polymyalgia rheumatica.
Sarilumab is available in injection (prefilled syringe)
and strengths such as 150 mg/1.14 mL, 200 mg/1.14 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Sarilumab is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Sarilumab can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing